Floatz logo

Therapeutic Asset Ratings

171 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
PROPRANOLOL
Ischemic Stroke
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3B (56)
Docetaxel
Adjuvant Therapy
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2/3CCC (55)
Benmelstobart
Ovarian Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP3CCC (54)
Serplulimab
Neoadjuvant Therapy
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (54)
Arimidex
HR+/HER2+ Early Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Arimidex
Luminal B/HER2-negative Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Benmelstobart
Fallopian Tube Cancers
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Calcium
HR+/HER2+ Early Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Capecitabine
Colon Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Catequentinib
Fallopian Tube Cancers
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
cc-5013
CHOP
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
cc-5013
Lenalidomide
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
cc-5013
Leucogen
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
cc-5013
Ribociclib
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Cetuximab
Advanced Metastatic Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Cetuximab
Safety
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Ckd-581
Leucogen
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Ckd-581
Ribociclib
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Clostridium Butyricum
Colon Neoplasm
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Cyclophosphamide
Lenalidomide
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
DALPICICLIB ISETIONATE
Luminal B/HER2-negative Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
DEXAMETHASONE
CHOP
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
DEXAMETHASONE
Lenalidomide
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
DEXAMETHASONE
Leucogen
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
DEXAMETHASONE
Ribociclib
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP2CCC (53)
Showing 51 to 75 of 171 assets
PreviousPage 3 of 7Next